Transducin-Like Enhancer of Split 3 (TLE3) expression is associated with taxane sensitivity in non-serous ovarian carcinoma in a three-cohort study

BACKGROUND: Chemo-resistance is a major challenge in ovarian cancer treatment, resulting in poor survival rates. Identifying markers of treatment response is imperative for improving outcome while minimizing unnecessary side effects. We have previously demonstrated that expression of transducin-like...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Cancer Epidemiol Biomarkers Prev
Egile Nagusiak: Ring, Brian Z., Murali, Rajmohan, Soslow, Robert A., Bowtell, David D.L., Fereday, Sian, deFazio, Anna, Traficante, Nadia, Kennedy, Catherine J, Brand, Alison, Sharma, Raghwa, Harnett, Paul, Samimi, Goli
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 2018
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC5984690/
https://ncbi.nlm.nih.gov/pubmed/29531130
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1055-9965.EPI-17-1101
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak